Things are finally looking up for Matthew Adams. As the top earner at MedCom Associates he has started to crawl out of the financial hole created during his "dark days." And now, out of the blue, a mysterious woman invites him to join a confidential research initiative. She says it will ease the mounting economic crisis. But at what cost to Matthew's fragile sanity, and his tortured soul?
